Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Common Stock history
Currency unavailable · from the balance sheet
No Common Stock data reported for this period type.
Common Stock vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €223.07M EUR | — | — | 134.7% |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $67K USD | +39.6% | +51.8% | 0.0% |
| Mar 2026 | $29K USD | -3.3% | -1.2% | 0.0% | |
| Sep 2026 | $16K USD | +23.1% | +35.7% | 0.0% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $12K USD | +20.0% | +108.0% | 0.0% |
| Mar 2026 | $11K USD | +37.5% | +31.0% | 0.0% | |
| Jun 2026 | $1K USD | +0.0% | — | 0.0% | |
| Mar 2026 | $1K USD | +0.0% | +0.0% | 0.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +20.0% | +33.4% | 0.0% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.